Canada Life’s NetEase NTES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
14,331
-932
-6% -$116K ﹤0.01% 1219
2025
Q4
$2.1M Hold
15,263
﹤0.01% 1146
2025
Q3
$2.31M Sell
15,263
-1,211
-7% -$167K ﹤0.01% 1167
2025
Q2
$2.22M Sell
16,474
-19,892
-55% -$2.29M ﹤0.01% 1153
2025
Q1
$3.75M Hold
36,366
0.01% 907
2024
Q4
$3.24M Buy
36,366
+10,137
+39% +$888K 0.01% 1049
2024
Q3
$2.46M Sell
26,229
-72,533
-73% -$6.33M ﹤0.01% 1210
2024
Q2
$9.45M Sell
98,762
-97,113
-50% -$9.24M 0.02% 571
2024
Q1
$20.3M Sell
195,875
-68,113
-26% -$6.96M 0.04% 388
2023
Q4
$24.5M Sell
263,988
-6,482,258
-96% -$689M 0.05% 326
2023
Q3
$52M Buy
6,746,246
+6,512,578
+2,787% +$668M 0.12% 156
2023
Q2
$22.7M Sell
233,668
-141,993
-38% -$12.8M 0.05% 337
2023
Q1
$33.3M Sell
375,661
-3,083
-0.8% -$266K 0.08% 252
2022
Q4
$27.6M Buy
378,744
+83,060
+28% +$5.65M 0.07% 276
2022
Q3
$22.3M Buy
295,684
+2,856
+1% +$251K 0.06% 305
2022
Q2
$27.3M Sell
292,828
-54,482
-16% -$5.18M 0.07% 272
2022
Q1
$32.9M Buy
347,310
+12,800
+4% +$1.22M 0.07% 288
2021
Q4
$33.9M Sell
334,510
-176,407
-35% -$17.9M 0.07% 285
2021
Q3
$43.9M Buy
510,917
+34,607
+7% +$3.27M 0.1% 208
2021
Q2
$54.9M Sell
476,310
-25,587
-5% -$2.82M 0.13% 172
2021
Q1
$51.6M Buy
501,897
+32,878
+7% +$3.72M 0.13% 173
2020
Q4
$44.8M Buy
469,019
+21,739
+5% +$1.95M 0.08% 247
2020
Q3
$40.6M Sell
447,280
-17,925
-4% -$1.69M 0.09% 227
2020
Q2
$39.9M Sell
465,205
-3,850
-0.8% -$290K 0.09% 225
2020
Q1
$30.2M Buy
469,055
+37,500
+9% +$2.47M 0.08% 247
2019
Q4
$26.3M Buy
431,555
+123,690
+40% +$7.25M 0.06% 337
2019
Q3
$16.4M Buy
307,865
+38,935
+14% +$1.98M 0.04% 420
2019
Q2
$13.7M Sell
268,930
-46,500
-15% -$2.47M 0.03% 470
2019
Q1
$15.2M Buy
315,430
+21,500
+7% +$1.02M 0.04% 379
2018
Q4
$13M Buy
293,930
+55,000
+23% +$2.48M 0.04% 395
2018
Q3
$10.9M Buy
238,930
+18,000
+8% +$828K 0.03% 499
2018
Q2
$11.2M Buy
220,930
+22,500
+11% +$1.15M 0.03% 508
2018
Q1
$11.1M Buy
198,430
+3,500
+2% +$220K 0.03% 493
2017
Q4
$13.4M Sell
194,930
-5,725
-3% -$358K 0.03% 439
2017
Q3
$10.3M Buy
200,655
+3,860
+2% +$222K 0.03% 511
2017
Q2
$11.8M Buy
196,795
+13,555
+7% +$777K 0.03% 455
2017
Q1
$10.4M Buy
183,240
+13,810
+8% +$744K 0.03% 488
2016
Q4
$7.32M Buy
169,430
+12,500
+8% +$597K 0.02% 570
2016
Q3
$7.55M Buy
156,930
+7,500
+5% +$319K 0.02% 562
2016
Q2
$5.76M Buy
149,430
+86,500
+137% +$2.69M 0.02% 630
2016
Q1
$1.8M Buy
62,930
+7,500
+14% +$225K 0.01% 740
2015
Q4
$2.01M Buy
+55,430
New +$1.73M 0.01% 730

Other funds holding NTES

Canada Life's NTES Position: Q1 2026 in Review

Canada Life reduced its NetEase (NTES) stake by 6.1% in Q1 2026, selling an estimated $116K and leaving 14,331 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Canada Life first reported a position in NTES in Q4 2015 and has held it in 42 quarters since. The position peaked at $54.9M in Q2 2021. 428 funds tracked by Wall St. Rank hold NTES as of Q1 2026.

  • Canada Life held 14,331 shares of NetEase worth $1.61M as of Q1 2026.
  • Canada Life sold 932 NetEase shares in Q1 2026, an estimated $116K.
  • NetEase made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1219 holding.
  • Canada Life first reported a position in NetEase in Q4 2015 and has held it in 42 quarters since.
  • Canada Life's NetEase position peaked at $54.9M in Q2 2021.
  • 428 funds tracked by Wall St. Rank held NetEase as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.